Bevacizumab in combination with temozolomide in the adjuvant treatment of newly diagnosed glioblastoma multiforme: Preliminary results of a phase II study

被引：0
|
作者：
Nicholas, M. K. [1 ,2 ,3 ,4 ]
Lucas, R. V. [1 ,2 ,3 ,4 ]
Arzbaecher, J. [1 ,2 ,3 ,4 ]
Paleologos, N. [1 ,2 ,3 ,4 ]
Krouwer, H. [1 ,2 ,3 ,4 ]
Malkin, M. [1 ,2 ,3 ,4 ]
Omar, A. [1 ,2 ,3 ,4 ]
Vick, N. A. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] NorthShore Univ Hlth Syst, Evanston, IL USA
[3] Waukesha Mem Hosp, Reg Canc Ctr, Waukesha, WI USA
[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2016
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly diagnosed glioblastoma multiforme (GBM).
    Friedman, Henry S.
    Desjardins, Annick
    Peters, Katherine B.
    Reardon, David A.
    Kirkpatrick, John
    Herndon, James Emmett
    Coan, April D.
    Bailey, Leighann
    Sampson, John Howard
    Friedman, Allan H.
    Vredenburgh, James J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Safety and efficacy of the addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma multiforme
    Vredenburgh, James J.
    Desjardins, Annick
    Peters, Katherine B.
    Reardon, David A.
    Herndon, James Emmett
    Coan, April D.
    Kirkpatrick, John
    Bailey, Leighann
    Threatt, Stevie
    Sampson, John Howard
    Friedman, Allan H.
    Friedman, Henry S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma
    Ahluwalia, Manmeet S.
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Figel, Sheila A.
    Mechtler, Laszlo L.
    Peereboom, David M.
    Hutson, Alan D.
    Withers, Henry G.
    Liu, Song
    Belal, Ahmed N.
    Qiu, Jingxin
    Mogensen, Kathleen M.
    Dharma, Sanam S.
    Dhawan, Andrew
    Birkemeier, Meaghan T.
    Casucci, Danielle M.
    Ciesielski, Michael J.
    Fenstermaker, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (07) : 1453 - +
  • [44] A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
    Rosenfeld, Myrna R.
    Ye, Xiaobu
    Supko, Jeffrey G.
    Desideri, Serena
    Grossman, Stuart A.
    Brem, Steven
    Mikkelson, Tom
    Wang, Daniel
    Chang, Yunyoung C.
    Hu, Janice
    McAfee, Quentin
    Fisher, Joy
    Troxel, Andrea
    Piao, Shengfu
    Heitjan, Daniel F.
    Tan, Kay See
    Pontiggia, Laura
    O'Dwyer, Peter J.
    Davis, Lisa E.
    Amaravadi, Ravi K.
    AUTOPHAGY, 2014, 10 (08) : 1359 - 1368
  • [45] PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Kavanagh, Brian D.
    NEURO-ONCOLOGY, 2011, 13 : 128 - 128
  • [46] Phase II - Study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations - Author reply
    Chinot, OL
    CANCER, 2004, 101 (12) : 2898 - 2899
  • [47] FIRST-LINE THERAPY WITH BEVACIZUMAB AND IRINOTECAN VERSUS BEVACIZUMAB AND TEMOZOLOMIDE AND DELAYED CONCOMITANT RADIOTHERAPY IN NEWLY DIAGNOSED PRIMARY GLIOBLASTOMA MULTIFORME: EARLY RESULTS FROM A RANDOMIZED PHASE II STUDY
    Hofland, Kenneth F.
    Poulsen, Hans Skovgaard
    Sorensen, Morten P.
    Ask, Anders
    Bertelsen, Anne K.
    Spahn-Horn, Silke
    Hansen, Steinbjorn
    Schulz, Henrik P.
    Lassen, Ulrik
    NEURO-ONCOLOGY, 2009, 11 (05) : 620 - 620
  • [48] Phase II trial of erlotinib with temozolomide and concurrent radiation therapy in patients with newly diagnosed glioblastoma multiforme: Final results
    Peereboom, D. M.
    Brewer, C. J.
    Sub, J. H.
    Stevens, G. H.
    Barnett, G. H.
    Toms, S. A.
    Elson, P.
    Vogelbaum, M. A.
    Weil, R. J.
    NEURO-ONCOLOGY, 2006, 8 (04) : 448 - 448
  • [49] Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma
    Wen, PY
    Gigas, DC
    MacDonald, L
    Batchelor, TT
    Schiff, D
    Xu, R
    Ramakrishna, N
    Weaver, S
    Kracher, J
    Bradshaw, J
    Levy, B
    Bailey, E
    Kesari, S
    Maher, EA
    Henson, J
    Black, PM
    NEURO-ONCOLOGY, 2004, 6 (04) : 385 - 385
  • [50] ECONOMIC EVALUATION OF TEMOZOLOMIDE FOR THE TREATMENT OF NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME IN MEXICO
    Rely, K.
    Salinas, E. G.
    Pierre, K. A.
    VALUE IN HEALTH, 2009, 12 (03) : A42 - A42
12345